RESULT TURNAROUND TIME OF RT-PCR FOR SARS-COV-2 IS THE MAIN CAUSE OF COVID-19 DIAGNOSTIC DELAY: A COUNTRY-WIDE OBSERVATIONAL STUDY OF MEXICO AND COLOMBIA

被引:0
|
作者
Nunez, Isaac [1 ]
Belaunzaran-Zamudio, Pablo F. [3 ]
Caro-Vega, Yanink [2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med Educ, Mexico City, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico
[3] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Bethesda, MD USA
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2022年 / 74卷 / 02期
关键词
SARS-CoV-2; COVID-19; Real-time polymerase chain reaction; Mexico; Colombia;
D O I
10.24875/RIC.21000542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Delay in COVID-19 diagnosis due to late real-time reverse transcription-polymerase chain reaction reporting has been described to be an important cause of suboptimal COVID-19 surveillance and outbreak containment. Objective: The objective of the study was to determine the duration of diagnostic delay due to test turnaround time and its association with marginalization status. Methods: In this observational study using national open data of Mexico and Colombia, we quantified the delay in COVID-19 diagnosis that occurred in both countries. We considered two periods that contributed to the delay in diagnosis: the time from symptom onset until testing (delay-one) and test turnaround time (delay-two). Marginalization status was determined according to country-specific scores. Results: Among 3,696,773 patients from Mexico and Colombia, delay-two was generally longer than delay-one. Median delay-one was 3 days and delay-two 7 days in Colombia, while in Mexico, they were 3 days and 4 days, respectively. In Colombia, worse marginalization status prolonged delay-two. In Mexico, a lower number and percentage of rapid tests were performed in areas with worse marginalization. Conclusion: Diagnostic delay was mostly due to test turnaround time. Marginalization status was an important barrier to diagnostic test access.
引用
收藏
页码:71 / 80
页数:10
相关论文
共 50 条
  • [41] SARS-CoV-2 RT-PCR test results across symptomatic COVID-19 cases in Auckland, New Zealand, February-June 2020
    Howe, Kevin
    Hale, Michael
    Reynolds, Gary Edwin
    COMMUNICABLE DISEASES INTELLIGENCE, 2021, 45
  • [42] Diagnostic Performance of Individual Symptoms to Predict SARS-CoV-2 RT-PCR Positivity and Symptom Persistence among Suspects Presenting in Primary Care during the First Wave of COVID-19
    Savoy, Mona
    Kopp, Benoit
    Chaouch, Aziz
    Cohidon, Christine
    Gouveia, Alexandre
    Lombardo, Patrick
    Maeder, Muriel
    Payot, Sylvie
    Perdrix, Jean
    Schwarz, Jolle
    Senn, Nicolas
    Mueller, Yolanda
    INFECTIOUS DISEASE REPORTS, 2023, 15 (01) : 112 - 124
  • [43] The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults
    Desai, Antonio
    Caltagirone, Giuseppe
    Sari, Sharon
    Pocaterra, Daria
    Kogan, Maria
    Azzolini, Elena
    Savevski, Victor
    Martinelli-Boneschi, Filippo
    Voza, Antonio
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 11
  • [44] Investigating the relationship between cycle threshold of SARS-CoV-2 RT-PCR, clinical features, and laboratory data in hospitalized COVID-19 patients in Semnan, Iran
    Neyestanaki, Mohammad Hassan Kalantar
    Gholizadeh, Omid
    Yasamineh, Saman
    Tarahomi, Mahdieh
    Pooya, Pegah
    Eslami, Majid
    Dadashpour, Mehdi
    Ghaffari, Hadi
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2025, 15
  • [45] Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study
    Wertenauer, Christoph
    Brenner Michael, Geovana
    Dressel, Alexander
    Pfeifer, Caroline
    Hauser, Ulrike
    Wieland, Eberhard
    Mayer, Christian
    Mutschmann, Caren
    Roskos, Martin
    Wertenauer, Hans-Joerg
    Moissl, Angela P.
    Lorkowski, Stefan
    Maerz, Winfried
    FRONTIERS IN MEDICINE, 2022, 9
  • [46] Prolonged SARS-CoV-2 RNA detection in anal/rectal swabs and stool specimens in COVID-19 patients after negative conversion in nasopharyngeal RT-PCR test
    Kipkorir, Vincent
    Cheruiyot, Isaac
    Ngure, Brian
    Misiani, Musa
    Munguti, Jeremiah
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2328 - 2331
  • [47] Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection among persons attending the RT-PCR center at a medical college hospital in Telangana: A case- control study
    Veerapu, Nagapraveen
    Inamdar, Dhanashree P.
    Kumar, Baer P. Ravi
    Anuradha, Basavaraju
    Guddanti, Pavitra
    Issapuri, Sree D.
    Ganta, Nikhita S.
    Gopi, Arun
    INDIAN JOURNAL OF COMMUNITY MEDICINE, 2022, 47 (04) : 587 - 590
  • [48] Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study
    Alonso-Canovas, Araceli
    Kurtis, Monica M.
    Gomez-Mayordomo, Victor
    Macias-Garcia, Daniel
    Viedma, Alvaro Gutierrez
    Rezola, Elisabet Mondragon
    Pagonabarraga, Javier
    Orgaz, Lidia Aranzabal
    Masjuan, Jaime
    Martinez-Castrillo, Juan Carlos
    Parees, Isabel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (09) : 776 - 777
  • [49] Quantitative analysis of RT-PCR test results for SARS-CoV-2 diagnostics across Poland during COVID-19 pandemic: Comparison between early stage and major pandemic waves in 2020 and 2021 with reference to SARS-CoV-2 variants
    Gierczynski, Rafal
    Czerw, Aleksandra
    Juszczyk, Grzegorz
    Charkiewicz, Radoslaw
    Niklinski, Jacek
    Majewski, Piotr
    Reszec, Joanna
    Piatyszek, Piotr
    Baniecki, Hubert
    Biecek, Przemyslaw
    Henry, Brandon Michael
    ADVANCES IN MEDICAL SCIENCES, 2022, 67 (02): : 386 - 392
  • [50] Saliva Quantification of SARS-CoV-2 in Real-Time PCR From Asymptomatic or Mild COVID-19 Adults
    Carrouel, Florence
    Gadea, Emilie
    Esparcieux, Aurelie
    Dimet, Jerome
    Langlois, Marie Elodie
    Perrier, Herve
    Dussart, Claude
    Bourgeois, Denis
    FRONTIERS IN MICROBIOLOGY, 2022, 12